Cargando…
2446. Clinical Spectrum and Outcomes of Colistin-Resistant Carbapenem-Resistant Enterobacteriaceae
BACKGROUND: Colistin is considered as one of the last resort of antibiotics against carbapenem-resistant enterobacteriaceae. During the last decade, increased use of colistin or polymyxins due to the increasing prevalence of carbapenem-resistant Gram-negative bacteria has unfortunately led to the em...
Autores principales: | Ahmed, Sara, Mahmood, Syed Faisal, Sharif, Fatima, Aijaz, Mariam, Awan, Safia, Jamil, Bushra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253246/ http://dx.doi.org/10.1093/ofid/ofy210.2099 |
Ejemplares similares
-
2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018) -
Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant Enterobacteriaceae
por: El-Mahallawy, Hadir A., et al.
Publicado: (2022) -
Colistin-resistance gene mcr in clinical carbapenem-resistant Enterobacteriaceae strains in China, 2014–2019
por: Huang, Hong, et al.
Publicado: (2020) -
Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy
por: Nasir, Nosheen, et al.
Publicado: (2019) -
Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran
por: Goudarzi, Zahra, et al.
Publicado: (2023)